Valeo Pharma Inc (TSE:VPH) has released an update.
Valeo Pharma Inc., a Canadian pharmaceutical company, has announced it will disclose its financial outcomes for Q1 2024 on March 14 after market close, followed by a conference call the next day. Interested parties can participate in the call via direct dial-in or automated call back by registering online. Valeo specializes in the commercialization of innovative prescription products in areas such as Respiratory/Allergy, Ophthalmology, and Hospital Specialty Products.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.
